| Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study A Hurria, K Togawa, SG Mohile, C Owusu, HD Klepin, CP Gross, ... Journal of clinical oncology 29 (25), 3457-3465, 2011 | 1950 | 2011 |
| Validation of a prediction tool for chemotherapy toxicity in older adults with cancer A Hurria, S Mohile, A Gajra, H Klepin, H Muss, A Chapman, T Feng, ... Journal of Clinical Oncology 34 (20), 2366-2371, 2016 | 621 | 2016 |
| Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update GA Masters, S Temin, CG Azzoli, G Giaccone, S Baker Jr, JR Brahmer, ... Journal of Clinical Oncology 33 (30), 3488-3515, 2015 | 570 | 2015 |
| Effect of number of lymph nodes sampled on outcome in patients with stage I non–small-cell lung cancer A Gajra, N Newman, GP Gamble, LJ Kohman, SL Graziano Journal of clinical oncology 21 (6), 1029-1034, 2003 | 363 | 2003 |
| Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib+ chemotherapy—Cancer and Leukemia Group B Trial 30203 MJ Edelman, D Watson, X Wang, C Morrison, RA Kratzke, S Jewell, ... Journal of Clinical Oncology 26 (6), 848-855, 2008 | 204 | 2008 |
| Frailty as determined by a comprehensive geriatric assessment‐derived deficit‐accumulation index in older patients with cancer who receive chemotherapy HJ Cohen, D Smith, CL Sun, W Tew, SG Mohile, C Owusu, HD Klepin, ... Cancer 122 (24), 3865-3872, 2016 | 186 | 2016 |
| The relationship between age, anxiety, and depression in older adults with cancer TR Weiss Wiesel, CJ Nelson, WP Tew, M Hardt, SG Mohile, C Owusu, ... Psycho‐Oncology 24 (6), 712-717, 2015 | 185 | 2015 |
| Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease A Gajra, N Newman, GP Gamble, NZ Abraham, LJ Kohman, SL Graziano Lung Cancer 42 (1), 51-57, 2003 | 162 | 2003 |
| Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: Effect on chemotherapy‐related toxicity and hospitalization … RJ Maggiore, W Dale, CP Gross, T Feng, WP Tew, SG Mohile, C Owusu, ... Journal of the American Geriatrics Society 62 (8), 1505-1512, 2014 | 161 | 2014 |
| Use of real-world evidence to support FDA approval of oncology drugs BA Feinberg, A Gajra, ME Zettler, TD Phillips, EG Phillips Jr, JK Kish Value in Health 23 (10), 1358-1365, 2020 | 96 | 2020 |
| Response of myasthenia gravis to rituximab in a patient with non‐Hodgkin lymphoma A Gajra, N Vajpayee, SJ Grethlein American journal of hematology 77 (2), 196-197, 2004 | 96 | 2004 |
| Phase I study of accelerated conformal radiotherapy for stage I non–small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904 JA Bogart, L Hodgson, SL Seagren, AW Blackstock, X Wang, R Lenox, ... Journal of clinical oncology 28 (2), 202-206, 2010 | 75 | 2010 |
| Barriers to chimeric antigen receptor T-cell (CAR-T) therapies in clinical practice A Gajra, A Zalenski, A Sannareddy, Y Jeune-Smith, K Kapinos, ... Pharmaceutical medicine 36 (3), 163-171, 2022 | 71 | 2022 |
| Phase III randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non–small-cell lung cancer with cyclooxygenase-2 … MJ Edelman, X Wang, L Hodgson, RT Cheney, MQ Baggstrom, ... Journal of Clinical Oncology 35 (19), 2184-2192, 2017 | 71 | 2017 |
| Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors A Gajra, HD Klepin, T Feng, WP Tew, SG Mohile, C Owusu, CP Gross, ... Journal of geriatric oncology 6 (2), 133-140, 2015 | 71 | 2015 |
| Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age J Ruiz, AA Miller, JA Tooze, S Crane, WJ Petty, A Gajra, HD Klepin Journal of geriatric oncology 10 (1), 48-54, 2019 | 70 | 2019 |
| American society of clinical oncology clinical practice. systemic therapy for stage IV non-small-cell lung cancer: American society of clinical oncology clinical practice … GA Masters, S Temin, CG Azzoli, G Giaccone, S Baker Jr, JR Brahmer, ... J Clin Oncol 33 (30), 3488-515, 2015 | 69 | 2015 |
| Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial FW Nugent, WC Mertens, S Graziano, N Levitan, R Collea, A Gajra, ... Lung Cancer 48 (2), 267-273, 2005 | 69 | 2005 |
| Efficacy of vorinostat in a murine model of polycythemia vera H Akada, S Akada, A Gajra, A Bair, S Graziano, RE Hutchison, G Mohi Blood, The Journal of the American Society of Hematology 119 (16), 3779-3789, 2012 | 63 | 2012 |
| Non–small-cell lung cancer in elderly patients: a discussion of treatment options A Gajra, A Jatoi Journal of Clinical Oncology 32 (24), 2562-2569, 2014 | 62 | 2014 |
